TScan Therapeutics, Inc.

TCRX · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$169,506$169,394$154,108$178,689
Short-Term Investments$14,947$48,651$97,581$111,421
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$3,712$3,085$3,147$2,612
Total Curr. Assets$188,165$221,130$254,836$292,722
Property Plant & Equip (Net)$68,741$70,618$71,087$71,599
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$5,031$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$288$6,813$6,786$6,797
Total NC Assets$74,060$77,431$77,873$78,396
Other Assets$0$0$0$0
Total Assets$262,225$298,561$332,709$371,118
Liabilities
Payables$6,353$4,539$4,966$4,278
Short-Term Debt$6,904$6,288$4,971$4,570
Tax Payable$0$0$0$0
Deferred Revenue$5,186$7,698$10,272$11,698
Other Curr. Liab.$10,765$12,797$9,607$15,410
Total Curr. Liab.$29,208$31,322$29,816$35,956
LT Debt$88,718$90,412$92,066$92,811
Deferred Rev, NC$0$0$501$1,246
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$278$113$124$135
Total NC Liab.$88,996$90,525$92,691$94,192
Other Liabilities$0$0$0$0
Cap. Leases$56,304$64,404$64,855$65,309
Total Liabilities$118,204$121,847$122,507$130,148
Equity
Pref Stock$0$0$0$0
Common Stock$6$6$6$6
Retained Earnings-$481,885-$446,175-$409,223-$375,096
AOCI$2-$4-$4$51
Other Equity$625,898$622,887$619,423$616,009
Total Equity$144,021$176,714$210,202$240,970
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$262,225$298,561$332,709$371,118
Net Debt-$73,884-$72,694-$57,071-$81,308
TScan Therapeutics, Inc. (TCRX) Financial Statements & Key Stats | AlphaPilot